424 related articles for article (PubMed ID: 9065059)
1. [Etiology and pathogenesis of insulin-dependent diabetes mellitus].
Klöppel G; Clemens A
Verh Dtsch Ges Pathol; 1996; 80():93-103. PubMed ID: 9065059
[TBL] [Abstract][Full Text] [Related]
2. [Insulin-dependent diabetes mellitus. Current aspects of morphology, etiology and pathogenesis].
Klöppel G; Clemens A
Pathologe; 1996 Jul; 17(4):269-75. PubMed ID: 8927593
[TBL] [Abstract][Full Text] [Related]
3. Insulin-Dependent Diabetes Mellitus: Islet Changes in Relation to Etiology and Pathogenesis.
Kloppel G; Clemens A
Endocr Pathol; 1997; 8(4):273-282. PubMed ID: 12114788
[TBL] [Abstract][Full Text] [Related]
4. Immunological disorders of type 1 diabetes mellitus.
Ziegler M; Ziegler B
Exp Clin Endocrinol; 1989 Sep; 94(1-2):97-114. PubMed ID: 2689194
[TBL] [Abstract][Full Text] [Related]
5. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
6. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
7. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
Ongagna JC; Levy-Marchal C
Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
[TBL] [Abstract][Full Text] [Related]
9. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
10. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes.
Keskinen P; Korhonen S; Kupila A; Veijola R; Erkkilä S; Savolainen H; Arvilommi P; Simell T; Ilonen J; Knip M; Simell O
Diabetologia; 2002 Dec; 45(12):1639-48. PubMed ID: 12488953
[TBL] [Abstract][Full Text] [Related]
11. A comparison of childhood and adult type I diabetes mellitus.
Karjalainen J; Salmela P; Ilonen J; Surcel HM; Knip M
N Engl J Med; 1989 Apr; 320(14):881-6. PubMed ID: 2648146
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
Thivolet C; Khallouf E
Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies in type 1 diabetes.
Taplin CE; Barker JM
Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
[TBL] [Abstract][Full Text] [Related]
14. [Result of 3 years of screening for preclinical phase of juvenile insulin-dependent diabetes mellitus].
Lesage C; Boitard C; Carel JC; Dauvergne M; Roger M; Chaussain JL; Bougnères PF
Arch Fr Pediatr; 1990 Dec; 47(10):709-13. PubMed ID: 2082843
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
16. Etiology and pathogenesis of type 1 diabetes.
Scherbaum WA
Horm Metab Res Suppl; 1992; 26():111-6. PubMed ID: 1490674
[TBL] [Abstract][Full Text] [Related]
17. [Islet-cell antibodies in juvenile diabetes mellitus (author's transl)].
Ludwig H; Schernthaner G; Mayr WR
Dtsch Med Wochenschr; 1977 Aug; 102(34):1221-4. PubMed ID: 334498
[TBL] [Abstract][Full Text] [Related]
18. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
[TBL] [Abstract][Full Text] [Related]
19. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of humoral and metabolic markers as an evaluation of risk for developing type 1 diabetes].
Młynarski W; Wyka K; Bodalska-ŁIpińska J; Andrzejewski W; Zmysłowska A; Bodalski J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):17-22. PubMed ID: 12831633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
